| 1 |
29682172 | Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. | 2018 Mar 30 |
3 |
| 2 |
30544712 | Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice. | 2018 Dec 10 |
3 |
| 3 |
22476054 | Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma. | 2012 May 1 |
2 |
| 4 |
20385788 | CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. | 2010 Jun 24 |
2 |